Soluble CD30 serum concentrations in active rheumatoid arthritis under the treatment of low-dose methotrexate

Basit Öğe Kaydı
dc.contributor.authorKamanli, A
dc.contributor.authorHacievliyagil, C
dc.contributor.authorGodekmerdan, A
dc.contributor.authorOzgocmen, S
dc.contributor.authorArdicoglu, O
dc.date.accessioned2026-08-12T18:12:54Z
dc.date.issued2003
dc.departmentFırat Üniversitesi
dc.descriptionAnnual European Congress of Rheumatology -- JUN 18, 2003 -- LISBON, PORTUGAL
dc.description.abstract[Abstract Not Available]
dc.identifier.endpage370
dc.identifier.issn0003-4967
dc.identifier.startpage370
dc.identifier.urihttps://hdl.handle.net/11508/64113
dc.identifier.volume62
dc.identifier.wosWOS:000224551401224
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherB M J Publishing Group
dc.relation.ispartofAnnals of the Rheumatic Diseases
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleSoluble CD30 serum concentrations in active rheumatoid arthritis under the treatment of low-dose methotrexate
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu